Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to discuss the Company’s record-breaking revenue for the June 24 quarter and for FY24.
He spoke of the growing adoption of Orthocell’s medical devices, Striate+™ and Remplir™, and the Company’s expansion plans to capture a significant share of the global dental bone regeneration and peripheral nerve repair markets.